322 related articles for article (PubMed ID: 21723852)
1. The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling.
Devallière J; Charreau B
Biochem Pharmacol; 2011 Nov; 82(10):1391-402. PubMed ID: 21723852
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of the adaptor Lnk (SH2B3) prevents porcine endothelial cell activation and apoptosis: implication for xenograft's cytoprotection.
Chatelais M; Devallière J; Galli C; Charreau B
Xenotransplantation; 2011; 18(2):108-20. PubMed ID: 21496118
[TBL] [Abstract][Full Text] [Related]
3. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.
Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L
Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264
[TBL] [Abstract][Full Text] [Related]
4. Role of the adaptor protein LNK in normal and malignant hematopoiesis.
Gery S; Koeffler HP
Oncogene; 2013 Jun; 32(26):3111-8. PubMed ID: 23045270
[TBL] [Abstract][Full Text] [Related]
5. [Sh2b3/Lnk family adaptor proteins in the regulation of lymphohematopoiesis].
Takaki S
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Dec; 31(6):440-7. PubMed ID: 19122374
[TBL] [Abstract][Full Text] [Related]
6. LNK mutations and myeloproliferative disorders.
McMullin MF; Cario H
Am J Hematol; 2016 Feb; 91(2):248-51. PubMed ID: 26660394
[TBL] [Abstract][Full Text] [Related]
7. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms.
Baran-Marszak F; Magdoud H; Desterke C; Alvarado A; Roger C; Harel S; Mazoyer E; Cassinat B; Chevret S; Tonetti C; Giraudier S; Fenaux P; Cymbalista F; Varin-Blank N; Le Bousse-Kerdilès MC; Kiladjian JJ; Velazquez L
Blood; 2010 Dec; 116(26):5961-71. PubMed ID: 20870899
[TBL] [Abstract][Full Text] [Related]
8. LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration.
Devallière J; Chatelais M; Fitau J; Gérard N; Hulin P; Velazquez L; Turner CE; Charreau B
FASEB J; 2012 Jun; 26(6):2592-606. PubMed ID: 22441983
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.
Oh ST; Simonds EF; Jones C; Hale MB; Goltsev Y; Gibbs KD; Merker JD; Zehnder JL; Nolan GP; Gotlib J
Blood; 2010 Aug; 116(6):988-92. PubMed ID: 20404132
[TBL] [Abstract][Full Text] [Related]
10. The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis.
Velazquez L
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):415-29. PubMed ID: 22990499
[TBL] [Abstract][Full Text] [Related]
11. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F.
Gery S; Cao Q; Gueller S; Xing H; Tefferi A; Koeffler HP
J Leukoc Biol; 2009 Jun; 85(6):957-65. PubMed ID: 19293402
[TBL] [Abstract][Full Text] [Related]
12. Mutation of SH2B3 (LNK), a genome-wide association study candidate for hypertension, attenuates Dahl salt-sensitive hypertension via inflammatory modulation.
Rudemiller NP; Lund H; Priestley JR; Endres BT; Prokop JW; Jacob HJ; Geurts AM; Cohen EP; Mattson DL
Hypertension; 2015 May; 65(5):1111-7. PubMed ID: 25776069
[TBL] [Abstract][Full Text] [Related]
13. Linking inflammation and hypertension via LNK/SH2B3.
Dale BL; Madhur MS
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):87-93. PubMed ID: 26717315
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha induces Lnk expression through PI3K-dependent signaling pathway in human umbilical vein endothelial cells.
Wan M; Li Y; Xue H; Li Q; Li J
J Surg Res; 2006 Nov; 136(1):53-7. PubMed ID: 17007883
[TBL] [Abstract][Full Text] [Related]
15. The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways.
Fitau J; Boulday G; Coulon F; Quillard T; Charreau B
J Biol Chem; 2006 Jul; 281(29):20148-59. PubMed ID: 16644735
[TBL] [Abstract][Full Text] [Related]
16. Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders.
Gery S; Gueller S; Chumakova K; Kawamata N; Liu L; Koeffler HP
Blood; 2007 Nov; 110(9):3360-4. PubMed ID: 17693582
[TBL] [Abstract][Full Text] [Related]
17. Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein.
Nobuhisa I; Takizawa M; Takaki S; Inoue H; Okita K; Ueno M; Takatsu K; Taga T
Mol Cell Biol; 2003 Dec; 23(23):8486-94. PubMed ID: 14612394
[TBL] [Abstract][Full Text] [Related]
18. Expression of the adaptor protein Lnk in leukemia cells.
Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
[TBL] [Abstract][Full Text] [Related]
19. [Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review].
Chen Y; Wu XQ; Han CS; Zhu P; Wei JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1309-12. PubMed ID: 24156456
[TBL] [Abstract][Full Text] [Related]
20. The function of SH2B3 (LNK) in the kidney.
Blass G; Mattson DL; Staruschenko A
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F682-F685. PubMed ID: 27440780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
